Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 7/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | AGXT | P21549 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.51 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL10795645 | 0.95 | HCAR2 (0.56) | ALDH1A1HCAR2MAOBMMP1MMP2 | |
| SCHEMBL6709375 | 0.87 | ALDH1A1 (0.73) | ALDH1A1HCAR2MAOBCYP3A4 | |
| SCHEMBL27486398 | 0.85 | MAOB (0.52) | ALDH1A1HCAR2MAOBMMP1MMP2 | |
| SCHEMBL20267543 | 0.85 | IDO1 (0.58) | HCAR2MAOBMMP1MMP2MMP9 | |
| SCHEMBL27698538 | 0.84 | HCAR2 (0.49) | ALDH1A1HCAR2MAOBMMP1MMP2 | |
| SCHEMBL20954673 | 0.83 | GLA (0.59) | HCAR2MAOBMMP1MMP2MMP9 | |
| SCHEMBL26038096 | 0.83 | HCAR2 (0.55) | HCAR2MAOBMMP1MMP2MMP9 | |
| SCHEMBL14852200 | 0.83 | MAOB (0.49) | ALDH1A1HCAR2MAOBMMP1MMP2 | |
| SCHEMBL14808170 | 0.83 | MAOB (0.56) | HCAR2MAOBMMP1MMP2MMP9 | |
| SCHEMBL11226742 | 0.82 | ALDH1A1 (0.61) | ALDH1A1HCAR2MAOBMMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020009176-A1 | AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF | 田辺三菱製薬株式会社 | 2020-01-09 | — | — | WO | disclosed |
| EP-2758377-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2758051-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| EP-2758050-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2014-07-30 | — | — | EP | disclosed |
| CN-101553483-B | 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors | HOFFMANN LA ROCHE | 2013-04-17 | — | — | CN | disclosed |
| WO-2013040863-A1 | CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043962-A1 | CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013043964-A1 | ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| CN-102816081-A | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | ABBOTT LAB | 2012-12-12 | — | — | CN | disclosed |
| CN-102666485-A | Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia | HOFFMANN LA ROCHE | 2012-09-12 | — | — | CN | disclosed |
| CN-101267811-A | Novel multi-cyclic compounds and their use | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2008-09-17 | — | — | CN | disclosed |
| CN-101142172-A | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | ABBOTT LAB (US) | 2008-03-12 | — | — | CN | disclosed |
| CN-1984894-A | Compounds and compositions as PPAR modulators | IRM LLC (BM) | 2007-06-20 | — | — | CN | disclosed |
| CN-1859903-A | Use of EP2 selective receptor agonists in medical treatment | PFIZER PROD INC (US) | 2006-11-08 | — | — | CN | disclosed |
| CN-1835924-A | Fused compounds that inhibit vanilloid receptor subtype 1(vr1) receptor | ABBOTT LAB (US) | 2006-09-20 | — | — | CN | disclosed |
| CN-1211367-C | Prostaglandin agonists and their use to treat bone disorders | PFIZER (US) | 2005-07-20 | — | — | CN | disclosed |
| CN-1566096-A | Prostaglandin agonists and their use to treat bonedisorders | PFIZER (US) | 2005-01-19 | — | — | CN | disclosed |
| CN-1275123-A | Prostaglandin agonists and their use to treat bone disorders | PFIZER (US) | 2000-11-29 | — | — | CN | disclosed |
| CN-1241176-A | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | PFIZER (US) | 2000-01-12 | — | — | CN | disclosed |
| US-4709081-A | ETHERIFICATION, HYDROLYSIS | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) | 1987-11-24 | — | — | US | disclosed |